virus phenotype, molecular epidemiology and improving diagnostic assays (OrbiNet) of Medical, Veterinary and Life Sciences, University of Glasgow ,Scotland (UK); Technical University of Denmark National Veterinary Institute, Lindholm Denmark; Institute of Animal Health, Pirbright GreatBritain Origin and evolution of recent virus incursions in the Mediterranean Basin 3 years Updating the BT epidemiological situation in Northern African countries and develop a new diagnostic tool capable of identifying and distinguishing BTV serotypes in one step Institut de la Recherche Vétérinaire Biopharma CroatianVeterinary Institute Tunisia Morocco Croatia Twinning project to strength the skill of the National Center for Zoosanitary Vigilance (CNVZ) 3 years To strength the skill of the CNVZ personnel on risk analysis and animal surveillance on BT and other infectious diseases National Center for Zoosanitary Vigilance Tunisia Identification of the Molecular determinants of BTV virulence 3 years To study the pathogenicity and identify possible molecular determinants of some field and vaccine BTV strains using mouse model and reverse genetics technique Faculty of Veterinary Medicine, Institute of Comparative Medicine, University of Glasgow United Kingdom Executive programme of scientific and technological cooperation between and South Africa Oral susceptibility of European and South African Culicoides species for European and South African bluetongue virus isolates Agricultural Research Council – Onderstepoort South Africa ToR: To collect, process, analyse, publish and disseminate epizootiological data relevant to the designated pathogens or diseases 12. Did your Laboratory collect epizootiological data relevant to international disease control?
X Yes No Test for which your laboratory is accredited Accreditation body VNT ACCREDIA BTV isolation ACCREDIA Real Time RT PCR ACCREDIA c-ELISA ACCREDIA 18. Does your laboratory maintain a “biorisk management system” for the pathogen and the disease concerned? (See Manual of Diagnostic Tests and Vaccines for Terrestrial Animals 2012, Chapter 1.1.3 or Manual of Diagnostic Tests for Aquatic Animals 2012, Chapter 1.1.1) X Yes No ToR: To organise and participate in scientific meetings on behalf of the OIE 19. Did your laboratory organise scientific meetings on behalf of the OIE? X Yes No National/ International Title of event Co-organiser Date (mm/yy) Location No. Participants International Kick-Off Meetings: “Origin and evolution of recent vector-borne virus incursions in the Mediterranean Basin” - 04/12 Teramo, Italy 22 International Assessment of the Institut de Recherche Agronomique du Liban – FANAR (IRAL) laboratories IRAL 03/12 Beirut, Lebanon 12 National 2° BT National Meeting 11/12 Teramo, Italy 44 20. Did your laboratory participate in scientific meetings on behalf of the OIE? X Yes No Title of event Date (mm/yy) Location Role (speaker, presenting poster, short communications) Title of the work presented EMIDA 2nd Partnership meeting 05/12 Paris Speaker BTV-related transplacental studies in Teramo 6th Annual Meeting EPIZONE “Viruses on the move” 06/12 Brighton Presenting poster Bluetongue virus detection in Culicoides biting midges in Italy